Achieve Life Sciences is a biotechnology business based in the US. Achieve Life Sciences shares (ACHV) are listed on the NASDAQ and all prices are listed in US Dollars. Achieve Life Sciences employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $4.89 |
|---|---|
| 52-week range | $3.03 - $5.98 |
| 50-day moving average | $4.96 |
| 200-day moving average | $4.55 |
| Wall St. target price | $18.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.26 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.89 from 2024-07-25
| 1 week (2024-07-19) | 5.62% |
|---|---|
| 1 month (2024-06-27) | 5.39% |
| 3 months (2024-04-26) | 6.07% |
| 6 months (2024-01-26) | -2.20% |
| 1 year (2023-07-27) | -8.77% |
|---|---|
| 2 years (2022-07-27) | -1.21% |
| 3 years (2021-07-27) | 7.25 |
| 5 years (2019-07-26) | 37 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -33.93% |
| Return on equity TTM | -109.49% |
| Profit margin | 0% |
| Book value | $1.44 |
| Market Capitalization | $159 million |
TTM: trailing 12 months
We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months.
Achieve Life Sciences's shares were split on a 1:20 basis on 30 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.
Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $3.03 up to $5.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.547. This would suggest that Achieve Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Achieve Life Sciences, Inc. , a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada. .
Learn how to invest in Cathie Wood’s ARK Venture Fund in 5 easy steps.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
Learn these options trading strategies to lock in profits and get acquainted with a new asset class.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.